Cargando…

High-resolution multilocus sequence typing for Chlamydia trachomatis: improved results for clinical samples with low amounts of C. trachomatis DNA

BACKGROUND: Several Multilocus Sequence Typing (MLST) schemes have been developed for Chlamydia trachomatis. Bom’s MLST scheme for MLST is based on nested PCR amplification and sequencing of five hypervariable genes and ompA. In contrast to other Chlamydia MLST schemes, Bom’s MLST scheme gives highe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilo, Shlomo, Zizelski Valenci, Gal, Rubinstein, Mor, Pichadze, Lea, Scharf, Yael, Dveyrin, Zeev, Rorman, Efrat, Nissan, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814548/
https://www.ncbi.nlm.nih.gov/pubmed/33461496
http://dx.doi.org/10.1186/s12866-020-02077-y
_version_ 1783638077007200256
author Pilo, Shlomo
Zizelski Valenci, Gal
Rubinstein, Mor
Pichadze, Lea
Scharf, Yael
Dveyrin, Zeev
Rorman, Efrat
Nissan, Israel
author_facet Pilo, Shlomo
Zizelski Valenci, Gal
Rubinstein, Mor
Pichadze, Lea
Scharf, Yael
Dveyrin, Zeev
Rorman, Efrat
Nissan, Israel
author_sort Pilo, Shlomo
collection PubMed
description BACKGROUND: Several Multilocus Sequence Typing (MLST) schemes have been developed for Chlamydia trachomatis. Bom’s MLST scheme for MLST is based on nested PCR amplification and sequencing of five hypervariable genes and ompA. In contrast to other Chlamydia MLST schemes, Bom’s MLST scheme gives higher resolution and phylogenetic trees that are comparable to those from whole genome sequencing. However, poor results have been obtained with Bom’s MLST scheme in clinical samples with low concentrations of Chlamydia DNA. RESULTS: In this work, we present an improved version of the scheme that is based on the same genes and MLST database as Bom’s MLST scheme, but with newly designed primers for nested-1 and nested-2 steps under stringent conditions. Furthermore, we introduce a third primer set for the sequencing step, which considerably improves the performance of the assay. The improved primers were tested in-silico using a dataset of 141 Whole Genome Sequences (WGS) and in a comparative analysis of 32 clinical samples. Based on cycle threshold and melting curve analysis values obtained during Real-Time PCR of nested-1 & 2 steps, we developed a simple scoring scheme and flow chart that allow identification of reaction inhibitors as well as to predict with high accuracy amplification success. The improved MLST version was used to obtain a genovars distribution in patients attending an STI clinic in Tel Aviv. CONCLUSIONS: The newly developed MLST version showed great improvement of assay results for samples with very low concentrations of Chlamydia DNA. A similar concept could be applicable to other MLST schemes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-020-02077-y.
format Online
Article
Text
id pubmed-7814548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78145482021-01-19 High-resolution multilocus sequence typing for Chlamydia trachomatis: improved results for clinical samples with low amounts of C. trachomatis DNA Pilo, Shlomo Zizelski Valenci, Gal Rubinstein, Mor Pichadze, Lea Scharf, Yael Dveyrin, Zeev Rorman, Efrat Nissan, Israel BMC Microbiol Methodology Article BACKGROUND: Several Multilocus Sequence Typing (MLST) schemes have been developed for Chlamydia trachomatis. Bom’s MLST scheme for MLST is based on nested PCR amplification and sequencing of five hypervariable genes and ompA. In contrast to other Chlamydia MLST schemes, Bom’s MLST scheme gives higher resolution and phylogenetic trees that are comparable to those from whole genome sequencing. However, poor results have been obtained with Bom’s MLST scheme in clinical samples with low concentrations of Chlamydia DNA. RESULTS: In this work, we present an improved version of the scheme that is based on the same genes and MLST database as Bom’s MLST scheme, but with newly designed primers for nested-1 and nested-2 steps under stringent conditions. Furthermore, we introduce a third primer set for the sequencing step, which considerably improves the performance of the assay. The improved primers were tested in-silico using a dataset of 141 Whole Genome Sequences (WGS) and in a comparative analysis of 32 clinical samples. Based on cycle threshold and melting curve analysis values obtained during Real-Time PCR of nested-1 & 2 steps, we developed a simple scoring scheme and flow chart that allow identification of reaction inhibitors as well as to predict with high accuracy amplification success. The improved MLST version was used to obtain a genovars distribution in patients attending an STI clinic in Tel Aviv. CONCLUSIONS: The newly developed MLST version showed great improvement of assay results for samples with very low concentrations of Chlamydia DNA. A similar concept could be applicable to other MLST schemes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-020-02077-y. BioMed Central 2021-01-18 /pmc/articles/PMC7814548/ /pubmed/33461496 http://dx.doi.org/10.1186/s12866-020-02077-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Methodology Article
Pilo, Shlomo
Zizelski Valenci, Gal
Rubinstein, Mor
Pichadze, Lea
Scharf, Yael
Dveyrin, Zeev
Rorman, Efrat
Nissan, Israel
High-resolution multilocus sequence typing for Chlamydia trachomatis: improved results for clinical samples with low amounts of C. trachomatis DNA
title High-resolution multilocus sequence typing for Chlamydia trachomatis: improved results for clinical samples with low amounts of C. trachomatis DNA
title_full High-resolution multilocus sequence typing for Chlamydia trachomatis: improved results for clinical samples with low amounts of C. trachomatis DNA
title_fullStr High-resolution multilocus sequence typing for Chlamydia trachomatis: improved results for clinical samples with low amounts of C. trachomatis DNA
title_full_unstemmed High-resolution multilocus sequence typing for Chlamydia trachomatis: improved results for clinical samples with low amounts of C. trachomatis DNA
title_short High-resolution multilocus sequence typing for Chlamydia trachomatis: improved results for clinical samples with low amounts of C. trachomatis DNA
title_sort high-resolution multilocus sequence typing for chlamydia trachomatis: improved results for clinical samples with low amounts of c. trachomatis dna
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814548/
https://www.ncbi.nlm.nih.gov/pubmed/33461496
http://dx.doi.org/10.1186/s12866-020-02077-y
work_keys_str_mv AT piloshlomo highresolutionmultilocussequencetypingforchlamydiatrachomatisimprovedresultsforclinicalsampleswithlowamountsofctrachomatisdna
AT zizelskivalencigal highresolutionmultilocussequencetypingforchlamydiatrachomatisimprovedresultsforclinicalsampleswithlowamountsofctrachomatisdna
AT rubinsteinmor highresolutionmultilocussequencetypingforchlamydiatrachomatisimprovedresultsforclinicalsampleswithlowamountsofctrachomatisdna
AT pichadzelea highresolutionmultilocussequencetypingforchlamydiatrachomatisimprovedresultsforclinicalsampleswithlowamountsofctrachomatisdna
AT scharfyael highresolutionmultilocussequencetypingforchlamydiatrachomatisimprovedresultsforclinicalsampleswithlowamountsofctrachomatisdna
AT dveyrinzeev highresolutionmultilocussequencetypingforchlamydiatrachomatisimprovedresultsforclinicalsampleswithlowamountsofctrachomatisdna
AT rormanefrat highresolutionmultilocussequencetypingforchlamydiatrachomatisimprovedresultsforclinicalsampleswithlowamountsofctrachomatisdna
AT nissanisrael highresolutionmultilocussequencetypingforchlamydiatrachomatisimprovedresultsforclinicalsampleswithlowamountsofctrachomatisdna